Biosensors for application in clinical diagnostics have recently been projected to have many advantages including increased assay speed, automation, flexibility, capability for multi-target analyses, reduced costs of diagnostic testing etc. Biosensor is an electronic device that can be used to detect a specific biological analyte by converting a biochemical reaction via a transducer (a signal conversion unit) into an electrical signal [1] [2] [3] [4] [5] . These bioelectronic devices have the potential to facilitate Point of Care Testing (POCT), where state-of-the-art molecular analysis can be carried out without requiring a state-of-the-art laboratory.
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Biosensors for cancer detection have recently aroused much interest. A major obstacle preventing faster development of these biodevices is that cancer is a highly complex set of diseases. Hence, new proteomic and genomic molecular tools are being used to evolve "molecular signatures" and to profile tumours. Oncologists presently currently heavily rely on a few biomarkers and histological characterization of tumors. Some of the signatures include epigenetic and genetic signatures, protein profiles ,changes in gene expression, and post-translational modifications of proteins. These molecular signatures offer new opportunities for development of biosensors for cancer detection.
Biosensors have enormous potential to contribute to the evolution of new molecular diagnostic techniques for patients suffering with cancerous diseases. In this context, quantum dots have recently been found to play an important role towards the fabrication of a biosensor for cancer detection. I will focus on results of some of the recent studies obtained in our laboratories relating to fabrication and application of nanomaterial based conducting paper based biosensors for cancer biomarker detection [3] [4] [5] .
